Developer docs
API playgroundTry for free, no card

Search company profiles

Lino Biotech

Full company profile

uuid000h7qo

Namestring
Lino Biotech
Legal namestring
Lino Biotech AG
Company typeenum
Private
Founded yearint
2020
Descriptiontext

Lino Biotech AG is a Swiss biotechnology company founded in 2020 and headquartered in Adliswil, Switzerland, that develops and commercializes focal molography — a label-free optical biosensing technology that measures coherent mass density via diffraction. The technology applies a spatial affinity lock-in principle to separate specific binding signals from environmental noise (temperature drift, non-specific binding, and matrix effects), enabling kinetic measurements directly in serum, plasma, cell lysate, and living cells where conventional SPR and BLI struggle. The flagship MACS Matchmaker instrument supports up to 64 simultaneous interactions on a single chip via DNA-directed immobilization (DDI), achieves sub-nanomolar KD resolution (0.3-0.8 nM), and delivers drift below 0.05 pg/mm²/min.

The company's product portfolio spans the MACS Matchmaker instrument, the MACS Sampler 768-well plate automation accessory, sensor chips, DNA adaptors, and a suite of application-specific assay panels targeting antibody developability: Polyreactivity (8- and 16-plex anchored to the Jain 2017 clinical-stage mAb benchmark), FcRn Species Panel, Fc Receptor Panel (8 Fc receptors including FcγRI, FcγRIIa/b, FcγRIIIa/b, FcεRI, FcεRII, and FcRn), Plasma Protein Binding (biologics up to 8-plex and small molecule up to 16-plex), DEL Hit Validation (up to 54 compounds per chip on-DNA without resynthesis), and PROTAC ternary complex characterization (up to 20 linker variants simultaneously). Revenue is generated through three streams: instrument sales (hardware), recurring consumables (chips, panels, kits sold via shop.lino-biotech.com), and application/service support. Pricing is not publicly disclosed.

Lino Biotech is a wholly-owned subsidiary of Miltenyi Biotec and serves drug discovery teams at biopharma and biotechnology companies engaged in antibody engineering, DNA-encoded library screening, and targeted protein degradation, alongside academic and research institutions. The company operates with 1-10 employees and pursues a sales-led go-to-market combining direct field sales (HubSpot-booked discovery calls), an e-commerce storefront, and Miltenyi Biotec's global distribution infrastructure. Scientific credibility is reinforced by an active peer-reviewed publication record in Analytical Chemistry, ACS Sensors, Biosensors, Journal of Medicinal Chemistry, and RSC Chemical Biology, plus conference presence at SLAS, PEGS, DEL Symposium, Festival of Biologics, ELRIG, BIO-Europe, and Drug Discovery Chemistry Europe.

Short descriptiontext

Lino Biotech AG is a Swiss subsidiary of Miltenyi Biotec that develops the MACS Matchmaker focal molography platform — a label-free biosensor enabling biomolecular interaction analysis directly in serum, lysate, and living cells for biopharma, biotech, and academic drug discovery customers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersAdliswil, Switzerland
HQ citystring
Adliswil
HQ countrystring
Switzerland
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
label-free biosensing, biomolecular interaction analysis, focal molography, antibody developability, drug discovery kinetics
Industry3 codes
PRIMARYHDAHALAK
Biosensors & Lab-on-Chip (BioMEMS)
SECONDARYHLAGAIAF
Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays)
SECONDARYHLAAALAL
Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays)
NAICS code1 code
  • Analytical Laboratory Instrument Manufacturing334516
SIC code1 code
  • Laboratory Analytical Instruments3826
Product category
Label-free Biosensor Instruments
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1MACS Matchmaker Instrument Sales
TypeHardware Sales
Description

Sale of the MACS Matchmaker label-free biosensor instrument to biopharma companies, biotechs, and academic labs performing biomolecular interaction analysis.

lino-biotech.com
2Consumables (Sensor Chips, Kits, DNA Adaptors)
TypeSubscription Recurring
Description

Recurring revenue from proprietary sensor chips, pre-conjugated ligand panels (Fc Receptor, Polyreactivity, Plasma Protein Binding), DNA adaptors, and ready-to-use kits. Consumables are sold via the online shop (shop.lino-biotech.com) and are designed for single-use on the MACS Matchmaker platform.

lino-biotech.com
3Service and Support
TypeProfessional Services
Description

Application science support and service offerings for customers using the MACS Matchmaker platform, including training, demonstration, and technical support services.

lino-biotech.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1MACS Matchmaker
Description

Label-free biosensor platform based on focal molography technology for biomolecular interaction analysis in complex biological matrices.

lino-biotech.com
Core offering1 text field

Lino Biotech develops and commercializes the MACS Matchmaker, a label-free biosensor instrument platform based on its proprietary focal molography technology. The platform measures biomolecular interaction kinetics directly in complex biological matrices such as serum, plasma, cell lysate, and living cells, supporting up to 64 simultaneous interactions per chip via DNA-directed immobilization. The company also sells proprietary sensor chips, DNA adaptors, application-specific assay panels (FcRn, Fc receptor, polyreactivity, plasma protein binding, DEL hit validation, PROTAC), capture reagents, and supporting services.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • Up to 500 kinetic measurements per day
+6 more records
Product overview1 text field

Lino Biotech offers the MACS® Matchmaker, a label-free biosensor platform built on focal molography technology. The platform comprises the main MACS Matchmaker instrument with integrated fluorescence imaging and automated sample handling, complemented by a portfolio of application-specific panels (Polyreactivity Panel, FcRn Species Panel, Fc Receptor Panel, Plasma Protein Binding Panel, DEL Hit Validation, PROTAC/TPD Panel), capture systems (Anti-Fc, Anti-His-tag, Anti-biotin), and sensor chip consumables with DNA-directed immobilization. The platform enables up to 64 simultaneous biomolecular interactions per chip, with measurements possible directly in complex biological matrices including serum, plasma, cell lysate, and living cells. Optional MACS Sampler automation enables high-throughput screening workflows.

Product and service15 records
1MACS Matchmaker
CategoryBiosensor Instrument
Description

Label-free biosensor instrument platform based on focal molography for biomolecular interaction analysis. Enables kinetics measurements in complex biological fluids (serum, cell lysates, living cells) with up to 64 simultaneous interactions per chip in single-cycle kinetics (SCK) and multi-cycle kinetics (MCK) modes. Sold to biopharma, biotech, and academic research customers.

2Sensor Chips
CategoryConsumables
Description

Pre-conjugated sensor chips for the MACS Matchmaker platform featuring DNA-directed immobilization (DDI) for ligand attachment. Support 8-plex and 16-plex panel configurations with defined ligand sets. Consumable sold to MACS Matchmaker users.

3DNA Adaptors
CategoryConsumables
Description

Oligonucleotide-based adaptor reagents for DNA-directed immobilization of ligands on sensor chips. Enable reversible, non-covalent capture of biomolecules. Consumable sold to MACS Matchmaker users.

4Kits
CategoryConsumables
Description

Ready-to-use assay kits for specific applications on the MACS Matchmaker platform, including pre-conjugated panels and necessary reagents. Sold to biopharma and biotech customers.

5Polyreactivity Panel
CategoryApplication Panel
Description

Developability screening panel that quantifies non-specific binding across 8 (Essentials) or 16 (Plus) liability axes including dsDNA, HSA, insulin, lysozyme, cardiolipin, heparin, and polyclonal human IgG. Returns a Polyreactivity Index anchored to the Jain et al. 2017 clinical-stage mAb benchmark in approximately 30 minutes. Used by antibody engineering teams in biopharma and biotech drug discovery.

6FcRn Species Panel
CategoryApplication Panel
Description

Cross-species half-life prediction panel for antibody FcRn binding characterization across multiple species. Enables approximately one-hour kinetics measurement for antibody half-life assessment. Sold to antibody engineering and pharmacokinetics teams in biopharma.

7Fc Receptor Panel
CategoryApplication Panel
Description

Effector function profiling panel covering activating, inhibitory, and polymorphic Fc receptors including FcγRI, FcγRIIa, FcγRIIb, FcγRIIIa, FcγRIIIb, FcεRI, FcεRII, and FcRn. Approximately one-hour kinetics for full effector function profile. Used by antibody engineering teams in biopharma and biotech.

8Plasma Protein Binding Panel
CategoryApplication Panel
Description

Plasma binding screening panel available in biologics (up to 8-plex) and small molecule (up to 16-plex) configurations. Profiles candidate binding to plasma carrier proteins including HSA, α1-acid glycoprotein, and lipoproteins directly in undiluted human plasma in approximately one hour. Used by drug discovery and DMPK teams.

9DEL Hit Validation
CategoryApplication Panel
Description

DNA-encoded library hit validation solution enabling on-DNA kinetic characterization of DEL hits directly from screen output without resynthesis. Supports up to 54 compounds per chip in a single injection. Used by DEL screening teams in biopharma and biotech.

10PROTAC Design / Targeted Protein Degradation
CategoryApplication Panel
Description

Ternary complex characterization panel for PROTACs and molecular glues. Enables cooperativity measurement directly from binding data in cell lysate, with multiplexed screening of 20 linker variants simultaneously. Used by targeted protein degradation teams in biopharma.

11Anti-Fc Capture System
CategoryCapture Reagent
Description

Oligonucleotide-conjugated recombinant fusion proteins (Protein A/G and Protein A/G/L) for fast, reversible antibody capture via Fc or light-chain regions. Supports various IgG subclasses and species without chemical labeling. Sold as capture reagent for MACS Matchmaker users.

12Anti-His-tag Capture System
CategoryCapture Reagent
Description

Oligo Adapter trisNTA capture system for fast, reversible immobilization of His-tagged proteins. Based on oligonucleotide-conjugated trisNTA chelator head for sensor chip attachment. Sold as capture reagent for MACS Matchmaker users.

13Anti-biotin Capture System
CategoryCapture Reagent
Description

NeutrAvidin-based capture system for immobilization and kinetic characterization of biotinylated molecules. Provides robust, low-background platform for affinity studies. Sold as capture reagent for MACS Matchmaker users.

14MACS Sampler
CategoryAutomation Accessory
Description

768-well plate automation accessory for high-throughput sample handling on the MACS Matchmaker. Enables processing of approximately 50-100 candidates per day for routine triage or full overnight developability screening runs. Sold to high-throughput screening labs.

15Application Science Services and Support
CategoryServices
Description

Application science support services for customers using the MACS Matchmaker platform, including training, demonstration, and technical support services from application scientists. Sold to biopharma and biotech customers alongside instrument and consumable purchases.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeOEM/ Whitelabel/ Licensing Partner
Description

Lino Biotech AG is a Miltenyi Biotec company. The MACS Matchmaker is branded and sold as a Miltenyi Biotec product, with the Lino Biotech website hosted at lino-biotech.com but linked from miltenyibiotec.com. The Miltenyi Biotec logo and brand assets (search, cart, account icons) are used on the Lino Biotech website. Miltenyi Biotec's global distribution network supports sales of the MACS Matchmaker platform. The company's LinkedIn page is linkedin.com/company/lino-biotech-ag.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Cytiva's Biacore line is the dominant surface plasmon resonance (SPR) platform for label-free biomolecular interaction analysis — the established incumbent whose pain points (matrix noise, drift, sequential throughput) focal molography directly attacks.

TypeDirect peer
Description

Sartorius's FortéBio Octet biolayer interferometry (BLI) platform is the other major label-free kinetics incumbent, widely used in antibody screening and characterization workflows that Lino Biotech's MACS Matchmaker targets.

TypeDirect peer
Description

Carterra's LSA (high-throughput SPR) platform competes directly in the antibody discovery and developability screening space, offering kinetic characterization at scale that overlaps with Lino's 64-plex workflow.

TypeDirect peer
Description

Gator Bio offers BLI-based label-free interaction analysis platforms (GatorPrime, GatorPlus) targeting antibody and biologics characterization — a direct functional peer in the kinetic analysis market.

TypeEmerging player
Description

Nicoya offers ALIS (Active Learning Interferometric Scattering) and OpenSPR label-free instruments, positioning as an emerging alternative in the label-free biosensing space with overlapping workflows.

TypeEmerging player
Description

Attana offers QCM-based label-free biosensor instruments for real-time biomolecular interaction analysis, targeting antibody and biomarker characterization workflows comparable to Lino's MACS Matchmaker applications.

TypeEmerging player
Description

BioNavis provides multi-parameter SPR (MP-SPR) instruments for label-free interaction analysis and biomolecular kinetics, addressing similar antibody and small molecule characterization use cases.

TypeBroad incumbent
Description

Bruker is a broad life sciences and analytical instrument incumbent offering label-free SPR products and adjacent biophysical characterization tools, with much wider product portfolio but overlapping biopharma customers.

TypeEmerging player
Description

XanTec Bioanalytics supplies SPR sensor chips and instrumentation for label-free interaction analysis, competing in the consumables and instruments space that supports MACS Matchmaker's addressable workflow.

TypeBroad incumbent
Description

Thermo Fisher is a broad life sciences tools incumbent whose biopharma instrumentation portfolio overlaps with the customer base Lino targets, although without a direct focal molography-equivalent product.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature10 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Lino Biotech

Label-free Biosensor Instrumentslino-biotech.com

Lino Biotech AG is a Swiss subsidiary of Miltenyi Biotec that develops the MACS Matchmaker focal molography platform — a label-free biosensor enabling biomolecular interaction analysis directly in serum, lysate, and living cells for biopharma, biotech, and academic drug discovery customers.

What Lino Biotech does

Lino Biotech AG is a Swiss biotechnology company founded in 2020 and headquartered in Adliswil, Switzerland, that develops and commercializes focal molography — a label-free optical biosensing technology that measures coherent mass density via diffraction. The technology applies a spatial affinity lock-in principle to separate specific binding signals from environmental noise (temperature drift, non-specific binding, and matrix effects), enabling kinetic measurements directly in serum, plasma, cell lysate, and living cells where conventional SPR and BLI struggle. The flagship MACS Matchmaker instrument supports up to 64 simultaneous interactions on a single chip via DNA-directed immobilization (DDI), achieves sub-nanomolar KD resolution (0.3-0.8 nM), and delivers drift below 0.05 pg/mm²/min.

The company's product portfolio spans the MACS Matchmaker instrument, the MACS Sampler 768-well plate automation accessory, sensor chips, DNA adaptors, and a suite of application-specific assay panels targeting antibody developability: Polyreactivity (8- and 16-plex anchored to the Jain 2017 clinical-stage mAb benchmark), FcRn Species Panel, Fc Receptor Panel (8 Fc receptors including FcγRI, FcγRIIa/b, FcγRIIIa/b, FcεRI, FcεRII, and FcRn), Plasma Protein Binding (biologics up to 8-plex and small molecule up to 16-plex), DEL Hit Validation (up to 54 compounds per chip on-DNA without resynthesis), and PROTAC ternary complex characterization (up to 20 linker variants simultaneously). Revenue is generated through three streams: instrument sales (hardware), recurring consumables (chips, panels, kits sold via shop.lino-biotech.com), and application/service support. Pricing is not publicly disclosed.

Lino Biotech is a wholly-owned subsidiary of Miltenyi Biotec and serves drug discovery teams at biopharma and biotechnology companies engaged in antibody engineering, DNA-encoded library screening, and targeted protein degradation, alongside academic and research institutions. The company operates with 1-10 employees and pursues a sales-led go-to-market combining direct field sales (HubSpot-booked discovery calls), an e-commerce storefront, and Miltenyi Biotec's global distribution infrastructure. Scientific credibility is reinforced by an active peer-reviewed publication record in Analytical Chemistry, ACS Sensors, Biosensors, Journal of Medicinal Chemistry, and RSC Chemical Biology, plus conference presence at SLAS, PEGS, DEL Symposium, Festival of Biologics, ELRIG, BIO-Europe, and Drug Discovery Chemistry Europe.

Lino Biotech firmographics

Firmographics
Name
Lino Biotech
Legal name
Lino Biotech AG
Website
https://lino-biotech.com
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
11–50 employees
Short description
Lino Biotech AG is a Swiss subsidiary of Miltenyi Biotec that develops the MACS Matchmaker focal molography platform — a label-free biosensor enabling biomolecular interaction analysis directly in serum, lysate, and living cells for biopharma, biotech, and academic drug discovery customers.
Ownership category
akta.pro rank

Lino Biotech industry classification

Industry
Product category
Label-free Biosensor Instruments
NAICS
Analytical Laboratory Instrument Manufacturing (334516)
SIC
Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHDAHALAK
Biosensors & Lab-on-Chip (BioMEMS)
SECONDARYHLAGAIAF
Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays)
SECONDARYHLAAALAL
Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays)

Keywords

  • Label-free biosensing
  • Biomolecular interaction analysis
  • Focal molography
  • Antibody developability
  • Drug discovery kinetics

Where Lino Biotech is headquartered

Location

Headquarters

HQ city
Adliswil
HQ country
Switzerland
HQ region
Europe

Offices1 record

Markets served

Lino Biotech business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations

Revenue model

  1. MACS Matchmaker Instrument Sales: Sale of the MACS Matchmaker label-free biosensor instrument to biopharma companies, biotechs, and academic labs performing biomolecular interaction analysis.
  2. Consumables (Sensor Chips, Kits, DNA Adaptors): Recurring revenue from proprietary sensor chips, pre-conjugated ligand panels (Fc Receptor, Polyreactivity, Plasma Protein Binding), DNA adaptors, and ready-to-use kits. Consumables are sold via the online shop (shop.lino-biotech.com) and are designed for single-use on the MACS Matchmaker platform.
  3. Service and Support: Application science support and service offerings for customers using the MACS Matchmaker platform, including training, demonstration, and technical support services.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Lino Biotech product offering

Product offering

Core offering

Lino Biotech develops and commercializes the MACS Matchmaker, a label-free biosensor instrument platform based on its proprietary focal molography technology. The platform measures biomolecular interaction kinetics directly in complex biological matrices such as serum, plasma, cell lysate, and living cells, supporting up to 64 simultaneous interactions per chip via DNA-directed immobilization. The company also sells proprietary sensor chips, DNA adaptors, application-specific assay panels (FcRn, Fc receptor, polyreactivity, plasma protein binding, DEL hit validation, PROTAC), capture reagents, and supporting services.

Product overview

Lino Biotech offers the MACS® Matchmaker, a label-free biosensor platform built on focal molography technology. The platform comprises the main MACS Matchmaker instrument with integrated fluorescence imaging and automated sample handling, complemented by a portfolio of application-specific panels (Polyreactivity Panel, FcRn Species Panel, Fc Receptor Panel, Plasma Protein Binding Panel, DEL Hit Validation, PROTAC/TPD Panel), capture systems (Anti-Fc, Anti-His-tag, Anti-biotin), and sensor chip consumables with DNA-directed immobilization. The platform enables up to 64 simultaneous biomolecular interactions per chip, with measurements possible directly in complex biological matrices including serum, plasma, cell lysate, and living cells. Optional MACS Sampler automation enables high-throughput screening workflows.

Differentiator

Problem solved

Functional benefit

Brands

  • MACS Matchmaker: Label-free biosensor platform based on focal molography technology for biomolecular interaction analysis in complex biological matrices.

Products and services

  • MACS Matchmaker Label-free biosensor instrument platform based on focal molography for biomolecular interaction analysis. Enables kinetics measurements in complex biological fluids (serum, cell lysates, living cells) with up to 64 simultaneous interactions per chip in single-cycle kinetics (SCK) and multi-cycle kinetics (MCK) modes. Sold to biopharma, biotech, and academic research customers.
  • Sensor Chips Pre-conjugated sensor chips for the MACS Matchmaker platform featuring DNA-directed immobilization (DDI) for ligand attachment. Support 8-plex and 16-plex panel configurations with defined ligand sets. Consumable sold to MACS Matchmaker users.
  • DNA Adaptors Oligonucleotide-based adaptor reagents for DNA-directed immobilization of ligands on sensor chips. Enable reversible, non-covalent capture of biomolecules. Consumable sold to MACS Matchmaker users.
  • Kits Ready-to-use assay kits for specific applications on the MACS Matchmaker platform, including pre-conjugated panels and necessary reagents. Sold to biopharma and biotech customers.
  • Polyreactivity Panel Developability screening panel that quantifies non-specific binding across 8 (Essentials) or 16 (Plus) liability axes including dsDNA, HSA, insulin, lysozyme, cardiolipin, heparin, and polyclonal human IgG. Returns a Polyreactivity Index anchored to the Jain et al. 2017 clinical-stage mAb benchmark in approximately 30 minutes. Used by antibody engineering teams in biopharma and biotech drug discovery.
  • FcRn Species Panel Cross-species half-life prediction panel for antibody FcRn binding characterization across multiple species. Enables approximately one-hour kinetics measurement for antibody half-life assessment. Sold to antibody engineering and pharmacokinetics teams in biopharma.
  • Fc Receptor Panel Effector function profiling panel covering activating, inhibitory, and polymorphic Fc receptors including FcγRI, FcγRIIa, FcγRIIb, FcγRIIIa, FcγRIIIb, FcεRI, FcεRII, and FcRn. Approximately one-hour kinetics for full effector function profile. Used by antibody engineering teams in biopharma and biotech.
  • Plasma Protein Binding Panel Plasma binding screening panel available in biologics (up to 8-plex) and small molecule (up to 16-plex) configurations. Profiles candidate binding to plasma carrier proteins including HSA, α1-acid glycoprotein, and lipoproteins directly in undiluted human plasma in approximately one hour. Used by drug discovery and DMPK teams.
  • DEL Hit Validation DNA-encoded library hit validation solution enabling on-DNA kinetic characterization of DEL hits directly from screen output without resynthesis. Supports up to 54 compounds per chip in a single injection. Used by DEL screening teams in biopharma and biotech.
  • PROTAC Design / Targeted Protein Degradation Ternary complex characterization panel for PROTACs and molecular glues. Enables cooperativity measurement directly from binding data in cell lysate, with multiplexed screening of 20 linker variants simultaneously. Used by targeted protein degradation teams in biopharma.
  • Anti-Fc Capture System Oligonucleotide-conjugated recombinant fusion proteins (Protein A/G and Protein A/G/L) for fast, reversible antibody capture via Fc or light-chain regions. Supports various IgG subclasses and species without chemical labeling. Sold as capture reagent for MACS Matchmaker users.
  • Anti-His-tag Capture System Oligo Adapter trisNTA capture system for fast, reversible immobilization of His-tagged proteins. Based on oligonucleotide-conjugated trisNTA chelator head for sensor chip attachment. Sold as capture reagent for MACS Matchmaker users.
  • Anti-biotin Capture System NeutrAvidin-based capture system for immobilization and kinetic characterization of biotinylated molecules. Provides robust, low-background platform for affinity studies. Sold as capture reagent for MACS Matchmaker users.
  • MACS Sampler 768-well plate automation accessory for high-throughput sample handling on the MACS Matchmaker. Enables processing of approximately 50-100 candidates per day for routine triage or full overnight developability screening runs. Sold to high-throughput screening labs.
  • Application Science Services and Support Application science support services for customers using the MACS Matchmaker platform, including training, demonstration, and technical support services from application scientists. Sold to biopharma and biotech customers alongside instrument and consumable purchases.

Quantifiable outcome

  • Up to 500 kinetic measurements per day
  • +6 more outcomes

Companies that use Lino Biotech

Customer profile

Segments2 records

Ideal customer profiles2 records

Lino Biotech technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature10 records

Lino Biotech partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Miltenyi BioteccoreOEM/ Whitelabel/ Licensing PartnerLino Biotech AG is a Miltenyi Biotec company. The MACS Matchmaker is branded and sold as a Miltenyi Biotec product, with the Lino Biotech website hosted at lino-biotech.com but linked from miltenyibiotec.com. The Miltenyi Biotec logo and brand assets (search, cart, account icons) are used on the Lino Biotech website. Miltenyi Biotec's global distribution network supports sales of the MACS Matchmaker platform. The company's LinkedIn page is linkedin.com/company/lino-biotech-ag.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Lino Biotech competitors and assessment

Company assessment

Direct peers

  • Cytiva (Biacore): Cytiva's Biacore line is the dominant surface plasmon resonance (SPR) platform for label-free biomolecular interaction analysis — the established incumbent whose pain points (matrix noise, drift, sequential throughput) focal molography directly attacks.
  • Sartorius (FortéBio Octet): Sartorius's FortéBio Octet biolayer interferometry (BLI) platform is the other major label-free kinetics incumbent, widely used in antibody screening and characterization workflows that Lino Biotech's MACS Matchmaker targets.
  • Carterra: Carterra's LSA (high-throughput SPR) platform competes directly in the antibody discovery and developability screening space, offering kinetic characterization at scale that overlaps with Lino's 64-plex workflow.
  • Gator Bio: Gator Bio offers BLI-based label-free interaction analysis platforms (GatorPrime, GatorPlus) targeting antibody and biologics characterization — a direct functional peer in the kinetic analysis market.

Emerging players

  • Nicoya Lifesciences: Nicoya offers ALIS (Active Learning Interferometric Scattering) and OpenSPR label-free instruments, positioning as an emerging alternative in the label-free biosensing space with overlapping workflows.
  • Attana: Attana offers QCM-based label-free biosensor instruments for real-time biomolecular interaction analysis, targeting antibody and biomarker characterization workflows comparable to Lino's MACS Matchmaker applications.
  • BioNavis: BioNavis provides multi-parameter SPR (MP-SPR) instruments for label-free interaction analysis and biomolecular kinetics, addressing similar antibody and small molecule characterization use cases.
  • XanTec Bioanalytics: XanTec Bioanalytics supplies SPR sensor chips and instrumentation for label-free interaction analysis, competing in the consumables and instruments space that supports MACS Matchmaker's addressable workflow.

Broad incumbents

  • Bruker: Bruker is a broad life sciences and analytical instrument incumbent offering label-free SPR products and adjacent biophysical characterization tools, with much wider product portfolio but overlapping biopharma customers.
  • Thermo Fisher Scientific: Thermo Fisher is a broad life sciences tools incumbent whose biopharma instrumentation portfolio overlaps with the customer base Lino targets, although without a direct focal molography-equivalent product.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Lino Biotech social profiles

Digital presence

Lino Biotech financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Lino Biotech leadership team

Management profile

Number of profiles

Profiles7 records

Lino Biotech funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Lino Biotech M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lino Biotech

What does Lino Biotech do?

Lino Biotech develops and commercializes the MACS Matchmaker, a label-free biosensor instrument platform based on its proprietary focal molography technology. The platform measures biomolecular interaction kinetics directly in complex biological matrices such as serum, plasma, cell lysate, and living cells, supporting up to 64 simultaneous interactions per chip via DNA-directed immobilization. The company also sells proprietary sensor chips, DNA adaptors, application-specific assay panels (FcRn, Fc receptor, polyreactivity, plasma protein binding, DEL hit validation, PROTAC), capture reagents, and supporting services.

Is Lino Biotech a public or private company?

Lino Biotech is a private company. It is classified as corporate owned and is currently operating.

When was Lino Biotech founded?

Lino Biotech was founded in 2020. It employs 11 to 50 people.

Where is Lino Biotech based?

Lino Biotech is headquartered in Adliswil, Switzerland, in the Europe region.

How does Lino Biotech make money?

Three revenue lines are on record. MACS Matchmaker Instrument Sales are the primary driver. The others are consumables (Sensor Chips, Kits, DNA Adaptors) and service and Support.

Who are Lino Biotech's main competitors?

Direct peers on record are Cytiva (Biacore), Sartorius (FortéBio Octet), Carterra and Gator Bio. Emerging players are Nicoya Lifesciences, Attana, BioNavis and XanTec Bioanalytics. Broad incumbents are Bruker and Thermo Fisher Scientific.

Does Lino Biotech have an API?

No public API is recorded for Lino Biotech.

What industry is Lino Biotech in?

Lino Biotech's product category is Label-free Biosensor Instruments. Its primary akta.pro industry code is HDAHALAK, Biosensors & Lab-on-Chip (BioMEMS), with a secondary code of HLAGAIAF, Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays). Its NAICS code is 334516 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireBGL Announces the Sale of lino Biotech to Miltenyi BiotecBrown Gibbons Lang & Company advised lino Biotech's sale to Miltenyi Biotec, a German biotech firm. The deal, initiated by BGL's Diagnostics team, was not disclosed. Miltenyi will acquire 100% of shares from investors including Roche Venture Fund and Hightech-Grunderfonds.bionity.comSuccessful exit: Miltenyi Biotec acquires biosensor company lino BiotechMiltenyi Biotec has acquired 100% of the shares of biosensor company lino Biotech, effective February 22, 2023. The transaction involves investors including Roche Venture Fund and High-Tech Gründerfonds (HTGF), with Brown Gibbons Lang & Company acting as financial advisor. This acquisition aims to combine lino's Focal Molography® platform with Miltenyi's cell and gene therapy capabilities to improve potency assays.startupticker.chGermany-based company acquires lino BiotechMiltenyi Biotec has acquired 100% of lino Biotech, a Zurich-based biosensor company known for its Focal Molography technology. Under the transaction terms, lino Biotech will remain headquartered in Zurich and expand its research and development capabilities. The acquisition aims to combine lino's biosensor platform with Miltenyi's cell and gene therapy expertise to lower costs and establish new standards for potency assays.PR NewswireMiltenyi Biotec acquires biosensor company lino BiotechMiltenyi Biotec has acquired 100% of the shares of biosensor company lino Biotech for an undisclosed sum. The acquisition aims to integrate lino's Focal Molography technology with Miltenyi's cellular therapy expertise to enhance potency assays and reduce costs in drug discovery and manufacturing. Lino's headquarters in Zurich will be expanded for continued research and development.